Zenabis Global Inc. s (TSX:ZENA) Maltese joint venture,
ZenPharm Limited, was given the green light to produce cannabis for medicinal and research purposes in the Mediterranean island country.
The license issued by the Malta Medicines Authority comes on the heels of receipt of the European Union Good Manufacturing Practices certification, which was issued by the same regulatory body in February.
The Canadian cannabis producer is now set to import in bulk from its facility in Atholville.
ZenPharm already inked a supply deal with a customer in Germany to provide a minimum volume of 500 kg per year.
In addition, ZenPharm agreed to accept shipments of up to 300kg from the Atholville-based facility through year-end.
Cannabis producer Hexo continues to bolster its financial warchest as it gears up for expansion into the U.S., announcing this week plans to sell up to $150 million worth of new shares over the next two years.
The Ottawa-based firm says it’s launching an at-the-market offering that will see it sell newly issued shares on the Toronto and New York stock exchanges through brokers A.G.P./Alliance Global Partners and BMO Capital Markets in the U.S. and BMO Nesbitt Burns in Canada.
Under the ATM offering, Hexo can issue the shares at its discretion, with the program slated to end no later than June 7, 2023.
Author Bio
Rich has been a Fool since 1998 and writing for the site since 2004. After 20 years of patrolling the mean streets of suburbia, he hung up his badge and gun to take up a pen full time. Having made the streets safe for Truth, Justice, and Krispy Kreme donuts, he now patrols the markets looking for companies he can lock up as long-term holdings in a portfolio.
His coverage reflects his passion for motorcycles, booze, and guns (though typically not all exercised at the same time), but his writing also covers the broader sectors of consumer goods, technology, and industrials. So follow along as he tries to break down complex topics to make them more understandable and useful to the average investor.
May 11, 2021 at 2:52 pm
Exclusive Interview with HEXO Corp. Co-Founder and CEO Sebastien St. Louis
HEXO Corp. (TSX: HEXO; NYSE: HEXO) is positioning itself as a top-three player in the Canadian recreational cannabis space, but the CPG company is aiming to take the top-two position soon. Co-Founder and CEO Sébastien St-Louis spoke with New Cannabis Ventures about the company’s acquisition of Zenabis Global, U.S. strategy and the beverage opportunity. The audio of the entire conversation is available at the end of this written summary.
HEXO has maintained continuity with its leadership, with members of the team like General Counsel Roch Vaillancourt, and added new members. Over the past few years, the company has brought onboard COO Donald Courtney and CFO Trent MacDonald.
HEXO Corp. (TSX:HEXO, NYSE:HEXO) announced Tuesday it has created an at-the-market equity program (“ATM program”) by which it could issue and sell up to CA$150 million ($124 million) of its shares.
Under the ATM program, shares can be sold from treasury to public, from time to time, and at the company’s discretion.
All shares sold under it will be made via “at-the-market distributions,” following the terms of an equity distribution agreement signed May 11, 2021 by the company, A.G.P./Alliance Global Partners and BMO Capital Markets Corp., as U.S. agents, and BMO Nesbitt Burns Inc., as Canadian agent.